Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

565 Articles

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 10, 2017 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, KLA-Tencor, Marathon Oil, Verifone and Many More

The top analyst upgrades, downgrades and initiations seen on Friday include AbbVie, KLA-Tencor, Marathon Oil and Verifone.

Jon C. Ogg | Mar 7, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Frontier Communications, Hyatt Hotels, Weatherford International and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday include AbbVie, Frontier Communications, Hyatt Hotels and Weatherford International.

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Lee Jackson | Feb 22, 2017 at 10:15 AM EST

Jefferies Makes Another Huge Change to Franchise Picks Portfolio

A new Jefferies research report features its third big change for 2017. Plus four top dividend-paying stocks that long like…

Chris Lange | Feb 10, 2017 at 8:35 AM EST

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far…

Lee Jackson | Feb 3, 2017 at 8:25 AM EST

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

Jefferies has made a third big change for 2017 by adding Marathon Petroleum to the Franchise Picks list. Plus, three…

Chris Lange | Jan 27, 2017 at 8:45 AM EST

AbbVie Slides on Mixed Q4 Earnings

AbbVie reported mixed fourth-quarter financial results and offered guidance before the markets opened on Friday.

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

Lee Jackson | Jan 23, 2017 at 9:55 AM EST

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks…

Chris Lange | Jan 22, 2017 at 10:40 AM EST

7 Key Earnings Coming This Week

24/7 Wall St. has put together a preview of AT&T, AbbVie, Starbucks and some of the major companies scheduled to…

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

1 … 23 24 25 26 27 … 38

AbbVie : ABBV

All AbbVie Articles

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Short Sellers Back Off Major Pharma

Top Analyst Upgrades and Downgrades: AbbVie, KLA-Tencor, Marathon Oil, Verifone and Many More

Top Analyst Upgrades and Downgrades: AbbVie, Frontier Communications, Hyatt Hotels, Weatherford International and Many More

Why Short Sellers Are Making a Massive Bet in Major Pharma

Jefferies Makes Another Huge Change to Franchise Picks Portfolio

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

7 Key Earnings Coming This Week

Major Pharma Short Interest Declines Ahead of Trump Comments

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients

Airline Stocks Heading Into Summer 2026: Pricing Power vs Cost Pressure

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

AbbVie : ABBV

All AbbVie Articles

Short Sellers Run for Cover From Major Pharma Stocks

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Short Sellers Back Off Major Pharma

Top Analyst Upgrades and Downgrades: AbbVie, KLA-Tencor, Marathon Oil, Verifone and Many More

Top Analyst Upgrades and Downgrades: AbbVie, Frontier Communications, Hyatt Hotels, Weatherford International and Many More

Why Short Sellers Are Making a Massive Bet in Major Pharma

Jefferies Makes Another Huge Change to Franchise Picks Portfolio

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Jefferies Adds Big Dividend-Paying Leader to Franchise Picks List

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017

7 Key Earnings Coming This Week

Major Pharma Short Interest Declines Ahead of Trump Comments

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Featured Reads

How Much Do You Really Need in Treasury Bonds to Replace a $50,000 Salary With Interest

Fed’s Rate Freeze Could Sting for Social Security Recipients